Results 261 to 270 of about 55,594 (335)

JAK Inhibitors as a Novel Approach to Autoimmune Bullous Diseases: A Review

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Autoimmune bullous diseases (AIBDs) are a group of chronic disorders characterized by blister formation resulting from abnormal immune responses. Janus kinase (JAK) inhibitors have emerged as promising therapeutic agents for AIBDs. This review discusses the use of JAK inhibitors—such as upadacitinib, baricitinib, tofacitinib, and abrocitinib, among ...
Olga Olisova   +9 more
wiley   +1 more source

Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies. [PDF]

open access: yesBiomedicines
Marino M   +8 more
europepmc   +1 more source

Drug eruption induced by the intake of comprehensive cold medicine: A case report. [PDF]

open access: yesMedicine (Baltimore)
Huang Y   +5 more
europepmc   +1 more source

The Enigma of Paradoxical Reactions to Biological Therapies. [PDF]

open access: yesIndian Dermatol Online J
Elbendary A   +6 more
europepmc   +1 more source

Drug Eruptions

open access: yesCleveland Clinic Journal of Medicine, 1935
openaire   +1 more source

Home - About - Disclaimer - Privacy